Answers are grounded in this paper and cite their sources.
Cross sectional analysis revealed impaired quality of life in vitiligo patients, suggesting VitiQol's importance for monitoring outcomes.
Background:Vitiligo is an acquired multifactorial pigmentary disorder of the skin affecting all ages. Emphasis needs to shift from assessing only the physical limitation of skin diseases to subtle psychological issues arising from the impact of the disease on patients. Despite the impressive track record of Dermatology Quality of Life Index (DLQI), there may be limitations in its assessment of the quality of life of persons with non-inflammatory skin diseases such as vitiligo. The objective of this study was to assess the quality of life of patients with vitiligo in Benin City, Edo State, Nigeria, using a vitiligo specific quality of life scale (VitiQol). Methods: This is a cross sectional analytical study among adult vitiligo patients who attended dermatology clinic, patients were recruitedconsecutively. Data was obtained using a four section interviewer administered questionnaire which included the VitiQol. Data wasanalysed using univariate analysis, chi-square, Fisher's exact, t-test, ANOVAand pearson's correlation coefficient. Results: Atotal of 40 patients with vitiligo were recruited.The mean age for the study group was 37.2513.31 (p = 0.69); male 24(60%) andfemales 16(40%). The mean score for VitiQol was 24.70+ 21.47 Conclusion: The quality of life of most vitiligo patients was impaired. The VitiQol is a valid scale for estimating QOLof vitiligo patients and is highly recommended as part of treatment protocol at first contact and subsequently during the course of management.
No takes yet. Share an insight, caveat, or question.
Ogunbor et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: